Daily Newsletter

31 October 2023

Daily Newsletter

31 October 2023

UK earmarks £21m for implementing AI tools in 64 NHS trusts

The implementation is intended to increase efficiency and reduce waiting times for patients.

October 31 2023

The UK Government is allocating £21m ($25.52m) to 64 NHS trusts in England to implement artificial intelligence (AI) tools for the faster diagnosis and treatment of lung cancer.

These AI tools will assist healthcare professionals in analysing X-rays and CT scans and are planned to be in place by winter.

The implementation is intended to increase efficiency and reduce waiting times for patients.

With over 600,000 chest X-rays performed monthly in England, this deployment is also expected to expedite accurate diagnoses.

According to a press statement, the Health and Social Care Secretary hosted a roundtable to discuss AI's integration in healthcare, focusing on reducing waiting lists, easing hospital pressures, automating tasks, and promoting independence in care settings.

AI has already shown improved patient outcomes in stroke networks, such as Brainomix e-Stroke, which speeds up treatment and enhances independence.

The roundtable highlighted safe AI deployment and the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing the AI-Airlock system to facilitate early AI use in NHS settings.

Additionally, a team from the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham has established international standards for developing AI systems, ensuring the use of diverse and inclusive datasets to address potential biases and enhance transparency.

Previously, the UK Government spent £123m on 86 AI technologies, benefiting patients in various areas, including stroke diagnosis, screening, cardiovascular monitoring, and home-based condition management.

UK Health and Social Care Secretary Steve Barclay said: “We are rolling out more cutting-edge AI technology across the NHS to help with quicker, more accurate diagnosis of lung cancer because patients deserve the best care possible.

“AI is already being used in the NHS to halve treatment times for stroke patients and to assist doctors in analysing brain scans, reducing the time between admission and treatment by more than one hour - saving valuable staff time and improving patient recovery.

“We’re building on this success to make sure lung cancer patients get the support they need when they need it.”

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close